Quotes

Topics also related to Quotes:

Search Stocks

Gainers & Losers

  • FTSE
  • NYSE
  • NASDAQ
  • AMEX
  • NIKKEI

Gainers

Symb Last Change Chg %
TALV.L 6.89 +1.99 +40.61
PER.L 236.00 +21.00 +9.77
BUMIP.L 225.00 +20.00 +9.76
AGGK.L 1,645.00 +129.00 +8.51
SYR.L 1,110.00 +77.00 +7.45

Losers

Symb Last Change Chg %
EXIL.L 215.00 -12.50 -5.49
CMS.L 52.25 -2.75 -5.00
IFL.L 9.85 -0.40 -3.90
UBM.L 650.00 -25.00 -3.70
WLF.L 130.75 -4.75 -3.51
Data as of Mon Dec 16, 2013 9:43pm GMT.
Source: Thomson Reuters

UPDATE 1-Imagination Tech slumps on smartphone slowdown

LONDON, Dec 11 - Imagination Technologies said a slowdown at the top end of the smartphone market would hit the number of chips shipped with its graphics and video technology in the second half of the year, sending its shares down 15 percent.

Imagination Tech slumps on smartphone slowdown

LONDON, Dec 11 - Imagination Technologies said slowdown at the top end of the smartphone market would hit the number of chips shipped using its graphics and video technology in the second half of the year, sending its shares down 15 percent.

BRIEF-Imagination Tech shares down on poor outlook

Dec 11 - Imagination Technologies Group PLC : * Tech shares down 12 percent after company reduces full-year shipment

BRIEF-Shire shares fall 3 percent after mixed dry eye drug results

Dec 6 - Shire PLC : * Shares fall 3 percent after mixed dry eye drug results * For more news, please click here

UPDATE 1-BTG's varicose vein treatment wins US approval

* Injectable foam treatment approved after long development

BTG's groundbreaking varicose veins treatment wins US approval

LONDON, Nov 26 - British pharmaceutical firm BTG said U.S. regulators had approved its groundbreaking varicose veins treatment that uses an injectable foam to dissolve the veins as an alternative to stripping.

BRIEF-Unilife up 21.4 percent premarket; reaches supply deal with Hikma Pharmaceuticals

NEW YORK, Nov 20 - Unilife Corp : * Up 21.4 percent to $3.40 in premarket; reaches supply deal with Hikma Pharmaceuticals

BRIEF-Horizon Pharma up 23 percent premarket; to buy U.S. rights for Vimovo drug

NEW YORK, Nov 19 - Horizon Pharma Inc : * Up 23 percent to $5.50 in premarket; to buy U.S. rights for Vimovo drug

BRIEF-EasyJet shares up 4 percent on strong results

Nov 19 - easyJet plc : * Shares up 4 percent on strong results * For more news, please click here

Software firm Aveva's enterprise solutions unit disappoints

LONDON, Nov 18 - Britain's Aveva Group PLC , whose software is used to design power plants, shipping and oil and gas facilities, said its enterprise solutions business delivered disappointing growth in the first half, sending its shares down nearly 10 percent.

No related earnings announcements are currently scheduled within the next 7 days.

Symb 4 wk rating
change
Current mean
rating
CSSG.L 3.00 to 1.00 Buy
TET.L 3.00 to 1.00 Buy
HARV.L 2.33 to 1.00 Buy
FLYB.L 2.33 to 1.00 Buy
SXX.L 2.67 to 1.50 Buy
Symb 4 wk rating
change
Current mean
rating
LATC.L 1.50 to 4.50 Underperform
HUMR.L 3.00 to 5.00 Sell
EGS.L 1.00 to 3.00 Hold
RMG.L 1.00 to 2.90 Hold
PRG.L 2.50 to 4.00 Underperform

Topics also related to Quotes: